PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 155 filers reported holding PRECIGEN INC in Q4 2020. The put-call ratio across all filers is 1.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $63,047 | +23.5% | 44,399 | 0.0% | 0.00% | +100.0% |
Q2 2023 | $51,059 | +8.5% | 44,399 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $47,063 | -30.3% | 44,399 | 0.0% | 0.00% | -50.0% |
Q4 2022 | $67,486 | -28.2% | 44,399 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $94,000 | +59.3% | 44,399 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $59,000 | -37.2% | 44,399 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $94,000 | -43.0% | 44,399 | 0.0% | 0.00% | -60.0% |
Q4 2021 | $165,000 | -25.7% | 44,399 | 0.0% | 0.01% | -16.7% |
Q3 2021 | $222,000 | -23.2% | 44,399 | 0.0% | 0.01% | -25.0% |
Q2 2021 | $289,000 | -5.6% | 44,399 | 0.0% | 0.01% | -27.3% |
Q1 2021 | $306,000 | -32.3% | 44,399 | 0.0% | 0.01% | -47.6% |
Q4 2020 | $452,000 | +191.6% | 44,399 | 0.0% | 0.02% | +162.5% |
Q3 2020 | $155,000 | – | 44,399 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
EMFO, LLC | 425,000 | $603,500 | 0.57% |
Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
First Washington CORP | 646,575 | $918,137 | 0.37% |
Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |